{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T06:15:45Z","timestamp":1778739345145,"version":"3.51.4"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T00:00:00Z","timestamp":1771632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T00:00:00Z","timestamp":1771632000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s00428-026-04447-9","type":"journal-article","created":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T07:40:28Z","timestamp":1771659628000},"page":"1175-1181","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Unveiling a new SORBS2::BRAF fusion in papillary thyroid carcinoma: insights from molecular diagnostics"],"prefix":"10.1007","volume":"488","author":[{"given":"Yuning","family":"Dai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Ni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aoni","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qilu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guodong","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enqiao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,21]]},"reference":[{"issue":"11","key":"4447_CR1","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1056\/NEJMra1501993","volume":"375","author":"JA Fagin","year":"2016","unstructured":"Fagin JA, Wells SA Jr. (2016) Biologic and clinical perspectives on thyroid cancer. N Engl J Med 375(11):1054\u20131067","journal-title":"N Engl J Med"},{"issue":"2","key":"4447_CR2","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/s41574-023-00920-6","volume":"20","author":"I Landa","year":"2024","unstructured":"Landa I, Cabanillas ME (2024) Genomic alterations in thyroid cancer: biological and clinical insights. Nat Rev Endocrinol 20(2):93\u2013110","journal-title":"Nat Rev Endocrinol"},{"issue":"3","key":"4447_CR3","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.cell.2014.09.050","volume":"159","author":"Integrated genomic characterization of papillary thyroid carcinoma","year":"2014","unstructured":"Integrated genomic characterization of papillary thyroid carcinoma (2014) Cell 159(3):676\u2013690","journal-title":"Cell"},{"issue":"4","key":"4447_CR4","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/j.path.2019.08.002","volume":"12","author":"MR Haroon Al Rasheed","year":"2019","unstructured":"Haroon Al Rasheed MR, Xu B (2019) Molecular alterations in thyroid carcinoma. Surg Pathol Clin 12(4):921\u2013930","journal-title":"Surg Pathol Clin"},{"issue":"6","key":"4447_CR5","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/S0092-8674(04)00215-6","volume":"116","author":"PT Wan","year":"2004","unstructured":"Wan PT et al (2004) Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF. Cell 116(6):855\u2013867","journal-title":"Cell"},{"issue":"6892","key":"4447_CR6","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/nature00766","volume":"417","author":"H Davies","year":"2002","unstructured":"Davies H et al (2002) Mutations of the BRAF gene in human cancer. Nature 417(6892):949\u2013954","journal-title":"Nature"},{"issue":"8","key":"4447_CR7","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1177\/10507256251363120","volume":"35","author":"MD Ringel","year":"2025","unstructured":"Ringel MD et al (2025) 2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer. Thyroid 35(8):841\u2013985","journal-title":"Thyroid"},{"issue":"4","key":"4447_CR8","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1158\/1541-7786.MCR-19-0529","volume":"18","author":"C Stangl","year":"2020","unstructured":"Stangl C et al (2020) Diverse BRAF gene fusions confer resistance to EGFR-targeted therapy via differential modulation of BRAF activity. Mol Cancer Res 18(4):537\u2013548","journal-title":"Mol Cancer Res"},{"issue":"17","key":"4447_CR9","doi-asserted-by":"publisher","first-page":"3812","DOI":"10.1158\/1078-0432.CCR-23-3981","volume":"30","author":"MF Chen","year":"2024","unstructured":"Chen MF et al (2024) Tumor-agnostic genomic and clinical analysis of BRAF fusions identifies actionable targets. Clin Cancer Res 30(17):3812\u20133823","journal-title":"Clin Cancer Res"},{"issue":"3","key":"4447_CR10","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1158\/2159-8290.CD-18-1321","volume":"9","author":"R Yaeger","year":"2019","unstructured":"Yaeger R, Corcoran RB (2019) Targeting alterations in the RAF-MEK pathway. Cancer Discov 9(3):329\u2013341","journal-title":"Cancer Discov"},{"issue":"11","key":"4447_CR11","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1038\/nm.3392","volume":"19","author":"P Lito","year":"2013","unstructured":"Lito P, Rosen N, Solit DB (2013) Tumor adaptation and resistance to RAF inhibitors. Nat Med 19(11):1401\u20131409","journal-title":"Nat Med"},{"issue":"12","key":"4447_CR12","doi-asserted-by":"publisher","first-page":"2458","DOI":"10.1038\/s41379-020-0638-5","volume":"33","author":"YH Chu","year":"2020","unstructured":"Chu YH et al (2020) Clinicopathologic features of kinase fusion-related thyroid carcinomas: an integrative analysis with molecular characterization. Mod Pathol 33(12):2458\u20132472","journal-title":"Mod Pathol"},{"issue":"4","key":"4447_CR13","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1038\/s41388-019-1021-1","volume":"39","author":"F Weinberg","year":"2020","unstructured":"Weinberg F et al (2020) Identification and characterization of a BRAF fusion oncoprotein with retained autoinhibitory domains. Oncogene 39(4):814\u2013832","journal-title":"Oncogene"},{"issue":"1","key":"4447_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01665-y","volume":"21","author":"E Renaud","year":"2022","unstructured":"Renaud E et al (2022) Multiomic analysis of papillary thyroid cancers identifies BAIAP2L1-BRAF fusion and requirement of TRIM25, PDE5A and PKC\u03b4 for tumorigenesis. Mol Cancer 21(1):195","journal-title":"Mol Cancer"},{"issue":"6","key":"4447_CR15","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1089\/thy.2017.0258","volume":"28","author":"H He","year":"2018","unstructured":"He H et al (2018) Identification of a recurrent LMO7-BRAF fusion in papillary thyroid carcinoma. Thyroid 28(6):748\u2013754","journal-title":"Thyroid"},{"key":"4447_CR16","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.cancergen.2022.06.006","volume":"266\u2013267","author":"R Lin","year":"2022","unstructured":"Lin R et al (2022) Patient with multiple genetically distinct thyroid nodules including papillary thyroid carcinoma harboring novel YWHAG-BRAF fusion. Cancer Genet 266\u2013267:51\u201356","journal-title":"Cancer Genet"},{"issue":"7","key":"4447_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.27707","volume":"66","author":"L Sisdelli","year":"2019","unstructured":"Sisdelli L et al (2019) AGK-BRAF is associated with distant metastasis and younger age in pediatric papillary thyroid carcinoma. Pediatr Blood Cancer 66(7):e27707","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"4447_CR18","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1172\/JCI23237","volume":"115","author":"R Ciampi","year":"2005","unstructured":"Ciampi R et al (2005) Oncogenic AKAP9-BRAF fusion is a novel mechanism of MAPK pathway activation in thyroid cancer. J Clin Invest 115(1):94\u2013101","journal-title":"J Clin Invest"},{"issue":"4","key":"4447_CR19","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1002\/ijc.29825","volume":"138","author":"JS Ross","year":"2016","unstructured":"Ross JS et al (2016) The distribution of BRAF gene fusions in solid tumors and response to targeted therapy. Int J Cancer 138(4):881\u2013890","journal-title":"Int J Cancer"},{"key":"4447_CR20","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/9710421","volume":"2020","author":"Y Shen","year":"2020","unstructured":"Shen Y et al (2020) Identification of potential biomarkers for thyroid cancer using bioinformatics strategy: a study based on GEO datasets. Biomed Res Int 2020:9710421","journal-title":"Biomed Res Int"},{"issue":"1","key":"4447_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26343-3","volume":"12","author":"W Pu","year":"2021","unstructured":"Pu W et al (2021) Single-cell transcriptomic analysis of the tumor ecosystems underlying initiation and progression of papillary thyroid carcinoma. Nat Commun 12(1):6058","journal-title":"Nat Commun"},{"issue":"1","key":"4447_CR22","first-page":"195","volume":"19","author":"Y Liu","year":"2020","unstructured":"Liu Y et al (2020) Bioinformatics analysis to screen key genes in papillary thyroid carcinoma. Oncol Lett 19(1):195\u2013204","journal-title":"Oncol Lett"},{"key":"4447_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113853","volume":"155","author":"S Zhang","year":"2022","unstructured":"Zhang S, Tong Y (2022) Advances in the previous two decades in our understanding of the post-translational modifications, functions, and drug perspectives of ArgBP2 and its family members. Biomed Pharmacother 155:113853","journal-title":"Biomed Pharmacother"},{"issue":"12","key":"4447_CR24","first-page":"2706","volume":"9","author":"B Yan","year":"2019","unstructured":"Yan B, Peng Z, Xing C (2019) SORBS2, mediated by MEF2D, suppresses the metastasis of human hepatocellular carcinoma by inhibitiing the c-Abl-ERK signaling pathway. Am J Cancer Res 9(12):2706\u20132718","journal-title":"Am J Cancer Res"},{"issue":"4","key":"4447_CR25","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1074\/jbc.M114.610725","volume":"290","author":"PV Anekal","year":"2015","unstructured":"Anekal PV, Yong J, Manser E (2015) Arg kinase-binding protein 2 (ArgBP2) interaction with \u03b1-actinin and actin stress fibers inhibits cell migration. J Biol Chem 290(4):2112\u20132125","journal-title":"J Biol Chem"},{"issue":"7287","key":"4447_CR26","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/nature08902","volume":"464","author":"PI Poulikakos","year":"2010","unstructured":"Poulikakos PI et al (2010) RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF. Nature 464(7287):427\u2013430","journal-title":"Nature"},{"issue":"1","key":"4447_CR27","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/oncolo\/oyad247","volume":"29","author":"N Rustgi","year":"2024","unstructured":"Rustgi N et al (2024) Combined RAF and MEK inhibition to treat activated non-V600 BRAF-altered advanced cancers. Oncologist 29(1):15\u201324","journal-title":"Oncologist"},{"issue":"12","key":"4447_CR28","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.1007\/s12094-022-02916-6","volume":"24","author":"MD Fenor","year":"2022","unstructured":"Fenor MD et al (2022) MEK inhibitor sensitivity in BRAF fusion-driven prostate cancer. Clin Transl Oncol 24(12):2432\u20132440","journal-title":"Clin Transl Oncol"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-026-04447-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-026-04447-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-026-04447-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T05:58:58Z","timestamp":1778738338000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00428-026-04447-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,21]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["4447"],"URL":"https:\/\/doi.org\/10.1007\/s00428-026-04447-9","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,21]]},"assertion":[{"value":"27 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent was obtained from the patient.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights"}},{"value":"CARE guidelines were followed.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Standard of reporting"}},{"value":"The authors declare no competing interests.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}